Ketoprofen NDC 0276-0506

NDC codes

FDA NDC Directory

Product NDC (as listed)0276-0506Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00276-0506Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0276-0506-10	00276050610	100 CAPSULE in 1 BOTTLE (0276-0506-10)Marketed from Sep 13, 2022

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ketoprofen
Generic name (nonproprietary): ketoprofen
Active ingredients: Ketoprofen — 50 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Misemer Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074014
Marketing start: Sep 13, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 0276-0506_4add4a71-ad1b-2577-e063-6294a90a3263SPL ID 4add4a71-ad1b-2577-e063-6294a90a3263SPL set ID d0f47ab6-29ff-df07-e053-2a95a90a2b51RxCUI 197854, 197855, 197856UNII 90Y4QC304KUPC 0302760504102, 0302760507103
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400276050610 followed by a unit qualifier and the quantity

Package 00276-0506-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 15, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of ketoprofen capsules USP and other treatment options before deciding to use ketoprofen capsules USP. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. Ketoprofen capsules USP are indicated for the management of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Ketoprofen capsules USP are indicated for the management of pain. Ketoprofen capsules USP are also indicated for treatment of primary dysmenorrhea.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074014

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074014
Product	Strength	Form · route	Labeler	Product NDC
Orudisketoprofen	Ketoprofen 75 mg/1	CapsuleOral	Allegis Pharmaceuticals, Inc.	28595-031
Ketoprofen	Ketoprofen 75 mg/1	CapsuleOral	Marnel Pharmaceuticals, Inc.	0682-0150
Ketoprofen	Ketoprofen 25 mg/1	CapsuleOral	Misemer Pharmaceuticals, Inc.	0276-0504
Ketoprofen	Ketoprofen 75 mg/1	CapsuleOral	Misemer Pharmaceuticals, Inc.	0276-0507
Ketoprofen	Ketoprofen 50 mg/1	CapsuleOral	Oncora Pharma, LLC	85477-111